Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

BioTroy Therapeutics

BioTroy Therapeutics is a biopharmaceutical company that treats cancer and immunological disorders.
2020
Lingan, Zhejiang, China

Innovation

Industry Problem

Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.

R&D Focus

Cancer biomarker discovery and treatment-response prediction

Innovative Solution

BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

42.21M

Last Funding Amount

27.85M

Last Funding Date

17-06-2025

Startup Stage

Early Stage

Lead Investors

Pudong Chuangtou, Cowin Venture, Longpan Investment, Shanghai Biomedical Industrial Equity Investment Fund, Shanghai SIIC Fund Management

About

BioTroy Therapeutics is engaged in tumor immunity and is used for multi-omics tumor analysis, receptor-ligand discovery, research on target signal transduction pathways, antibody discovery and engineering, drug efficacy and large animal translational medicine, biomarkers, and precision medicine.

Something missing or incorrect on this page? Help us enrich this information